Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 3/2021

01-03-2021 | Correction

Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

Authors: Yuta Maruki, Chigusa Morizane, Yasuhito Arai, Masafumi Ikeda, Makoto Ueno, Tatsuya Ioka, Atsushi Naganuma, Masayuki Furukawa, Nobumasa Mizuno, Tadashi Uwagawa, Naminatsu Takahara, Masashi Kanai, Akinori Asagi, Satoshi Shimizu, Atsushi Miyamoto, Seigo Yukisawa, Makoto Kadokura, Yasushi Kojima, Junji Furuse, Takako Eguchi Nakajima, Kentaro Sudo, Noritoshi Kobayashi, Natsuko Hama, Takeharu Yamanaka, Tatsuhiro Shibata, Takuji Okusaka

Published in: Journal of Gastroenterology | Issue 3/2021

Login to get access

Excerpt

In the original publication of the article, the supplementary figure 2 was published wrongly. The correct supplementary figure 2 has been updated in Springer Link. …
Metadata
Title
Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)
Authors
Yuta Maruki
Chigusa Morizane
Yasuhito Arai
Masafumi Ikeda
Makoto Ueno
Tatsuya Ioka
Atsushi Naganuma
Masayuki Furukawa
Nobumasa Mizuno
Tadashi Uwagawa
Naminatsu Takahara
Masashi Kanai
Akinori Asagi
Satoshi Shimizu
Atsushi Miyamoto
Seigo Yukisawa
Makoto Kadokura
Yasushi Kojima
Junji Furuse
Takako Eguchi Nakajima
Kentaro Sudo
Noritoshi Kobayashi
Natsuko Hama
Takeharu Yamanaka
Tatsuhiro Shibata
Takuji Okusaka
Publication date
01-03-2021
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 3/2021
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-020-01755-y

Other articles of this Issue 3/2021

Journal of Gastroenterology 3/2021 Go to the issue

Letter to the Editor

Proton pump inhibitors and the risk of pancreatic cancer

Original Article—Alimentary Tract

Optimal cutoff value of integrated relaxation pressure on the esophagogastric junction to detect outflow obstruction using starlet high-resolution manometry system

Review

Evidence-based clinical practice guidelines for irritable bowel syndrome 2020

Letter to the Editor

Proton pump inhibitors and the risk of pancreatic cancer

Original Article—Liver, Pancreas, and Biliary Tract

Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

Original Article—Liver, Pancreas, and Biliary Tract

Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits